🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Advanced Solid Tumors With Homozygous MTAP Deletion

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680Phase 258 sites📍 San Francisco📍 Aurora📍 Atlanta Bristol-Myers Squibb · Tests: BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors NCT07077434Phase 112 sites📍 Beijing📍 Fuzhou📍 Guangzhou Bristol-Myers Squibb · Tests: BMS-986504 Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors NCT06414460Phase 1, Phase 210 sites📍 Denver📍 New Haven📍 Indianapolis InSilico Medicine Hong Kong Limited · Tests: ISM3412 Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion NCT05245500Phase 125 sites📍 Phoenix📍 Lone Tree📍 Jacksonville Bristol-Myers Squibb · Tests: MRTX1719 A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion NCT06672523Phase 13 sites📍 Budapest📍 Logroño📍 Madrid Bristol-Myers Squibb · Tests: BMS-986504, [14C]-BMS-986504 A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors NCT07469982Phase 11 site📍 Shanghai Shouyao Holdings (Beijing) Co. LTD · Tests: SY-9453
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy